NP101
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NP101, covering 2013-03-20 to 2016-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period [Phase 1]